Aethlon Medical
AEMD
14 hedge funds and large institutions have $1.51M invested in Aethlon Medical in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
54% more capital invested
Capital invested by funds: $975K → $1.51M (+$531K)
27% more funds holding
Funds holding: 11 → 14 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$301K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$124K |
| 3 |
SAM
Shamrock Asset Management
Dallas,
Texas
|
+$53K |
| 4 |
VF
Virtu Financial
New York
|
+$53K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$35.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$17.7K |
AEMD Hedge Fund Activity: Q1 2018 in Review
14 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2018, worth a combined $1.51M — up 54% from $975K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AEMD positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $301K. The largest seller was Bank of America, exiting entirely with an estimated $17.7K sold.
- 14 institutional investors held Aethlon Medical (AEMD) as of Q1 2018, up from 11 in Q4 2017.
- Funds reported $1.51M of Aethlon Medical stock for Q1 2018, up 54% quarter-over-quarter.
- 4 funds opened new Aethlon Medical positions in Q1 2018 and 1 closed out, a net change of +3 holders.
- The largest Aethlon Medical buyer in Q1 2018 was Millennium Management, an estimated $301K added.
- The largest Aethlon Medical seller in Q1 2018 was Bank of America, an estimated $17.7K sold.
Based on aggregated 13F filings for Q1 2018.